IND Exempt Trials No Longer “Deemed” Covered By Medicare, CMS Says
Executive Summary
Clinical trials that are exempt from FDA's investigational new drug process would no longer automatically qualify for Medicare coverage under CMS' proposed Clinical Research Policy